- Correspondence to editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy”
-
Wang Q, Bu Q, Zhou H, Lu L
- KMID: 2560116
- Clin Mol Hepatol.
- 2024 Oct;30(4):1026-1027.
- doi: 10.3350/cmh.2024.0470
-
- CITED
-
- Close
- SHARE
-
- Close
- Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy
-
Wang Q, Bu Q, Xu Z, Liang Y, Zhou J, Pan Y, Zhou H, Lu L
- KMID: 2557399
- Clin Mol Hepatol.
- 2024 Jul;30(3):515-538.
- doi: 10.3350/cmh.2024.0107
Background/Aims: Metabolic dysfunction-associated steatohepatitis (MASH) is an unmet clinical challenge due to the rapid increased occurrence but lacking approved drugs. Autophagy-related protein 16-like 1 (ATG16L1) plays an important role in... -
- CITED
-
- Close
- SHARE
-
- Close
